Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386222220> ?p ?o ?g. }
- W4386222220 endingPage "13288" @default.
- W4386222220 startingPage "13288" @default.
- W4386222220 abstract "Dyslipidemias have emerged as prevalent disorders among patients, posing significant risks for the development and progression of cardiovascular diseases. These conditions are characterized by elevated levels of total cholesterol (TC), triglycerides (TGs), and low-density lipoprotein cholesterol (LDL-C). This review delves into the current treatment approach, focusing on equalizing these parameters while enhancing the overall quality of life for patients. Through an extensive analysis of clinical trials, we identify disorders that necessitate alternative treatment strategies, notably familial hypercholesterolemia. The primary objective of this review is to consolidate existing information concerning drugs with the potential to revolutionize dyslipidemia management significantly. Among these promising pharmaceuticals, we highlight alirocumab, bempedoic acid, antisense oligonucleotides, angiopoietin-like protein inhibitors, apolipoprotein C-III (APOC3) inhibitors, lomitapide, and cholesterol ester transfer protein (CETP) inhibitors. Our review demonstrates the pivotal roles played by each of these drugs in targeting specific parameters of lipid metabolism. We outline the future landscape of dyslipidemia treatment, envisaging a more tailored and effective therapeutic approach to address this widespread medical concern." @default.
- W4386222220 created "2023-08-29" @default.
- W4386222220 creator A5036654092 @default.
- W4386222220 creator A5037767798 @default.
- W4386222220 creator A5055736019 @default.
- W4386222220 creator A5071020532 @default.
- W4386222220 creator A5079497275 @default.
- W4386222220 creator A5081918019 @default.
- W4386222220 creator A5091376568 @default.
- W4386222220 creator A5092238868 @default.
- W4386222220 date "2023-08-27" @default.
- W4386222220 modified "2023-10-01" @default.
- W4386222220 title "Advances in Treatment of Dyslipidemia" @default.
- W4386222220 cites W1520609538 @default.
- W4386222220 cites W1641785681 @default.
- W4386222220 cites W1968211431 @default.
- W4386222220 cites W2001328643 @default.
- W4386222220 cites W2037883104 @default.
- W4386222220 cites W2039816840 @default.
- W4386222220 cites W2039944972 @default.
- W4386222220 cites W2059426381 @default.
- W4386222220 cites W2083160599 @default.
- W4386222220 cites W2101185950 @default.
- W4386222220 cites W2102238081 @default.
- W4386222220 cites W2110157797 @default.
- W4386222220 cites W2119138136 @default.
- W4386222220 cites W2129506504 @default.
- W4386222220 cites W2165624352 @default.
- W4386222220 cites W2166934777 @default.
- W4386222220 cites W2193242203 @default.
- W4386222220 cites W2291773302 @default.
- W4386222220 cites W2405171365 @default.
- W4386222220 cites W2485118186 @default.
- W4386222220 cites W2586892149 @default.
- W4386222220 cites W2592844101 @default.
- W4386222220 cites W2606275751 @default.
- W4386222220 cites W2606712766 @default.
- W4386222220 cites W2612881219 @default.
- W4386222220 cites W2747264648 @default.
- W4386222220 cites W2770845637 @default.
- W4386222220 cites W2771247031 @default.
- W4386222220 cites W2778792421 @default.
- W4386222220 cites W2785715927 @default.
- W4386222220 cites W2789328009 @default.
- W4386222220 cites W2793658995 @default.
- W4386222220 cites W2808641584 @default.
- W4386222220 cites W2809105267 @default.
- W4386222220 cites W2892911593 @default.
- W4386222220 cites W2899997727 @default.
- W4386222220 cites W2900034165 @default.
- W4386222220 cites W2903079271 @default.
- W4386222220 cites W2922038538 @default.
- W4386222220 cites W2937406445 @default.
- W4386222220 cites W2945023400 @default.
- W4386222220 cites W2945128165 @default.
- W4386222220 cites W2953804067 @default.
- W4386222220 cites W2966503756 @default.
- W4386222220 cites W2991285252 @default.
- W4386222220 cites W3004789732 @default.
- W4386222220 cites W3011544274 @default.
- W4386222220 cites W3016411960 @default.
- W4386222220 cites W3019109939 @default.
- W4386222220 cites W3019123317 @default.
- W4386222220 cites W3020009704 @default.
- W4386222220 cites W3021549637 @default.
- W4386222220 cites W3030044481 @default.
- W4386222220 cites W3033177481 @default.
- W4386222220 cites W3038301709 @default.
- W4386222220 cites W3039853434 @default.
- W4386222220 cites W3042368998 @default.
- W4386222220 cites W3061843793 @default.
- W4386222220 cites W3072652402 @default.
- W4386222220 cites W3080152512 @default.
- W4386222220 cites W3080449802 @default.
- W4386222220 cites W3081911237 @default.
- W4386222220 cites W3082667831 @default.
- W4386222220 cites W3089328347 @default.
- W4386222220 cites W3097051212 @default.
- W4386222220 cites W3119117185 @default.
- W4386222220 cites W3132201940 @default.
- W4386222220 cites W3134156560 @default.
- W4386222220 cites W3142840603 @default.
- W4386222220 cites W3146677450 @default.
- W4386222220 cites W3146917501 @default.
- W4386222220 cites W3163173829 @default.
- W4386222220 cites W3167208319 @default.
- W4386222220 cites W3170272938 @default.
- W4386222220 cites W3183857127 @default.
- W4386222220 cites W3198320369 @default.
- W4386222220 cites W3205422331 @default.
- W4386222220 cites W3211803164 @default.
- W4386222220 cites W3216396211 @default.
- W4386222220 cites W4200420452 @default.
- W4386222220 cites W4205868548 @default.
- W4386222220 cites W4206437067 @default.
- W4386222220 cites W4206654024 @default.
- W4386222220 cites W4206703572 @default.
- W4386222220 cites W4210502889 @default.